Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Cash Flow Reinvestment Rate
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Cash Flow Reinvestment Rate of 0.52x as of September 2025, reinvesting CN¥652.49 Million (capex CN¥652.49 Million ) from operating cash flow of CN¥1.25 Billion. Explore 600866 capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Starlake Bioscience Co Inc Zhaoqing Guangdong Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for Starlake Bioscience Co Inc Zhaoqing Guangdong across 25 annual periods. Also explore how large is Starlake Bioscience Co Inc Zhaoqing Guan's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year capital reinvestment analysis for Starlake Bioscience Co Inc Zhaoqing Guangdong. For live market cap and broader valuation context, see Starlake Bioscience Co Inc Zhaoqing Guan market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.67x | CN¥2.16 Billion | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +358.2% |
| 2024 | 0.36x | CN¥873.65 Million | CN¥2.40 Billion | CN¥638.50 Million | ▼ -40.2% |
| 2023 | 0.61x | CN¥1.23 Billion | CN¥2.03 Billion | CN¥375.83 Million | ▲ +26.3% |
| 2022 | 0.48x | CN¥802.34 Million | CN¥1.66 Billion | CN¥452.34 Million | ▼ -57.0% |
| 2021 | 1.12x | CN¥216.26 Million | CN¥192.63 Million | CN¥205.08 Million | ▼ -6.8% |
| 2020 | 1.20x | CN¥301.07 Million | CN¥249.99 Million | CN¥289.89 Million | ▲ +52.3% |
| 2019 | 0.79x | CN¥168.59 Million | CN¥213.17 Million | CN¥157.41 Million | ▲ +16.3% |
| 2018 | 0.68x | CN¥34.46 Million | CN¥50.69 Million | CN¥33.71 Million | ▼ -83.6% |
| 2017 | 4.14x | CN¥165.61 Million | CN¥40.05 Million | CN¥40.61 Million | ▲ +158.8% |
| 2016 | 1.60x | CN¥65.78 Million | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.9% |
| 2015 | 75.72x | CN¥207.87 Million | CN¥2.75 Million | CN¥103.49 Million | ▲ +480.4% |
| 2011 | 13.05x | CN¥859.52 Million | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥396.40 Million | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥62.60 Million | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥49.97 Million | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥74.90 Million | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥77.37 Million | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥69.77 Million | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥220.76 Million | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥110.12 Million | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥88.18 Million | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥77.35 Million | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥67.16 Million | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥79.45 Million | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥113.73 Million | CN¥71.14 Million | CN¥113.73 Million | — |